Category Archives: IP

Spending Rises on Prescription Drugs, Despite Overall Slowdown in Healthcare Outlays

More new medicines came to market in 2013, and fewer blockbuster drugs lost patent protection, trends that federal analysts say led to more rapid growth in outlays for prescription drugs in 2013. Retail prescription drug spending rose 2.5% to reach $271 billion a year ago, much faster than the low growth rate of 0.5% in […]
Also posted in drug spending, healthcare, pricing | Tagged , , | 1 Comment

Strong IP Plans Essential for UK Life Sciences Clusters

By John Dean, Withers & Rogers LLP. Life sciences and biotech research clusters across the UK, including those linked to university research departments are benefiting from an improved funding climate and ongoing consolidation in the pharmaceutical sector. However, as big pharma companies increasingly vie for the best spin-out investment opportunities, those with strategic intellectual property […]
Also posted in Biotech, Europe, Global, Guest Blog, Strategy | Tagged , , , | Leave a comment

Bureaucratic Roadblocks Threaten Biopharma Growth

Ahead of the BIO International Convention next week, Jim Greenwood, President and CEO of the Biotechnology Industry Organization, writes that protecting intellectual property rights is vital to biopharma innovation. There is a clear link between a country’s rate of economic development and the strength of its intellectual property laws. This is particularly true in knowledge-intensive […]
Also posted in Biotech, FDA, Guest Blog, Regulatory | Tagged , , , , | Leave a comment

Antibiotics Discovery: Time for a ‘Manhattan Project’

by Susan Crowley The innovative pharmaceutical industry is under attack from critics around the world for failing to develop new antibiotics to treat emerging infections. The charge has been furthered by statements from World Health Organization (WHO) director Margaret Chan. In 2012, she warned that bacteria were starting to become so resistant to common antibiotics […]
Also posted in Corporate Responsibility, Global, Guest Blog, healthcare, leadership, Manufacturing, Market Access, R&D, Strategy | Tagged , , , , , , , | 4 Comments

After Delays, Project DataSphere Rolls Out

An industry and academic data-sharing project went live on Tuesday, nearly a year after the platform was expected to launch. Visitors to the site – no credentials needed – can register and access de-identified clinical data from the comparator arms of nine oncology trials, with more to come. Project DataSphere, the newest data transparency and […]
Also posted in Biotech, Corporate Responsibility, Europe, FDA, Global, leadership, Legal, R&D, Strategy, Technology | Tagged , , , , , , , , , | Leave a comment
  • Categories

  • Meta